CRISPR Therapeutics
VerifiedGene-based medicines for patients with serious diseases
Launch date
Employees
Ownership
Market cap
$4.7b
Net debt
$4.9b
Firm valuation
$5.3b (Public information from Jan 2022)
Share price
$60.77 CRSP
Basel Canton of Basel-Stadt (HQ)